Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)

Clinical trial NCT06977711 · RECRUITING

Trial details

NCT number: NCT06977711
Sponsor: The University of Texas Health Science Center at San Antonio
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma

Start date: 2025-06-20
Primary completion: 2026-10-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.